NCT01206595View on ClinicalTrials.gov

Safety, Efficacy, and Pharmacokinetics of SKY0402 Administered as a Nerve Block in Subjects Undergoing Bunionectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

December 31, 2006

Conditions
Postoperative Pain
Interventions
DRUG

SKY0402

Single dose of SKY0402 administered as a nerve block

DRUG

Bupivacaine HCl

Single dose of 125 mg administered as a nerve block

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY